Insider Trading activities of Dermira, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dermira, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dermira, Inc. since year 2005. Table 2 shows the detailed insider transactions of Dermira, Inc. since 2005. The reporting company's ticker symbol is DERM. The reporting company's CIK number is 1557883.
The total value of stock buying since 2005 is $16,052,730.
The total value of stock sales since 2005 is $8,416,569.
The total value of stock option exercises since 2005 is $490,927.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dermira, Inc. (DERM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-02 0 $0 9,303 $279,624 6,803 $14,857
2017-01 0 $0 12,303 $378,125 9,803 $17,815
2016-12 0 $0 15,303 $474,519 1,803 $9,927
2016-11 0 $0 16,903 $547,390 5,903 $32,518
2016-10 0 $0 23,703 $818,798 12,703 $69,986
2016-09 0 $0 37,803 $1,253,503 26,803 $147,677
2016-08 0 $0 25,303 $813,380 18,226 $64,739
2016-07 0 $0 24,803 $738,986 11,303 $57,027
2016-06 0 $0 33,500 $1,018,720 20,000 $26,510
2016-05 0 $0 11,500 $288,715 0 $0
2016-04 0 $0 9,500 $196,930 0 $0
2016-02 0 $0 11,500 $316,977 0 $0
2016-01 0 $0 13,500 $452,665 0 $0
2015-12 0 $0 2,500 $75,050 0 $0
2015-11 0 $0 2,500 $69,375 0 $0
2015-10 0 $0 2,500 $57,962 0 $0
2015-09 0 $0 22,500 $635,850 0 $0
2015-06 0 $0 0 $0 9,051 $49,871
2014-11 6,000 $100,602 0 $0 0 $0
2014-10 997,008 $15,952,128 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dermira, Inc. insiders (DERM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-02-15 Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) Sale 1,303 30.95 40,330
2017-02-15 Griffith Christopher M. (SVP Head Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2017-02-15 Ringo William R Sale 500 32.00 16,000
2017-02-15 Ringo William R Option Ex 500 16.00 8,000
2017-02-14 Bauer Eugene A (Chief Medical Officer) Sale 1,505 30.00 45,153
2017-02-01 Bauer Eugene A (Chief Medical Officer) Sale 995 30.00 29,851
2017-02-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 5,000 29.66 148,290
2017-02-01 Wiggans Thomas G (CEO & Chairman of the Board) Option Ex 5,000 .99 4,930
2017-01-17 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 29.51 38,451
2017-01-17 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2017-01-04 Ringo William R Sale 500 32.00 16,000
2017-01-04 Ringo William R Option Ex 500 16.00 8,000
2017-01-04 Wiggans Thomas G (CEO & Chairman of the Board) Sale 3,000 32.51 97,542
2017-01-04 Wiggans Thomas G (CEO & Chairman of the Board) Option Ex 3,000 .99 2,958
2017-01-03 Bauer Eugene A (Chief Medical Officer) Sale 2,500 30.07 75,172
2017-01-03 Wiggans Thomas G (CEO & Chairman of the Board) Sale 5,000 30.19 150,960
2017-01-03 Wiggans Thomas G (CEO & Chairman of the Board) Option Ex 5,000 .99 4,930
2016-12-16 Ringo William R Sale 125 32.00 4,000
2016-12-16 Ringo William R Option Ex 125 16.00 2,000
2016-12-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 30.70 40,004
2016-12-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2016-12-14 Bauer Eugene A (Chief Medical Officer) Sale 2,500 30.85 77,130
2016-12-01 Ringo William R Sale 375 32.00 12,000
2016-12-01 Ringo William R Option Ex 375 16.00 6,000
2016-12-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 31.04 341,385
2016-11-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 34.20 44,569
2016-11-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2016-11-09 Ringo William R Sale 500 32.30 16,149
2016-11-09 Ringo William R Option Ex 500 16.00 8,000
2016-11-09 Guggenhime Andrew (COO and CFO) Sale 4,100 35.02 143,582
2016-11-09 Guggenhime Andrew (COO and CFO) Option Ex 4,100 5.51 22,591
2016-11-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 31.19 343,090
2016-10-17 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 32.33 42,125
2016-10-17 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2016-10-11 Guggenhime Andrew (COO and CFO) Sale 10,900 34.66 377,848
2016-10-11 Guggenhime Andrew (COO and CFO) Option Ex 10,900 5.51 60,059
2016-10-03 Ringo William R Sale 500 34.25 17,125
2016-10-03 Ringo William R Option Ex 500 16.00 8,000
2016-10-03 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 34.70 381,700
2016-09-19 Guggenhime Andrew (COO and CFO) Sale 15,000 35.01 525,150
2016-09-19 Guggenhime Andrew (COO and CFO) Option Ex 15,000 5.51 82,650
2016-09-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 32.77 42,698
2016-09-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2016-09-12 Guggenhime Andrew (COO and CFO) Sale 10,000 32.53 325,300
2016-09-12 Guggenhime Andrew (COO and CFO) Option Ex 10,000 5.51 55,100
2016-09-01 Ringo William R Sale 500 32.00 16,000
2016-09-01 Ringo William R Option Ex 500 16.00 8,000
2016-09-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 31.30 344,355
2016-08-15 Pena Luis C. (Chief Development Officer) Option Ex 1,000 .00 0
2016-08-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 31.75 41,370
2016-08-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,663 .99 1,639
2016-08-15 Guggenhime Andrew (COO and CFO) Option Ex 1,188 .00 0
2016-08-15 Bauer Eugene A (Chief Medical Officer) Option Ex 875 .00 0
2016-08-15 Wiggans Thomas G (CEO & Chairman of the Board) Option Ex 3,000 .00 0
2016-08-11 Guggenhime Andrew (COO and CFO) Sale 10,000 31.02 310,170
2016-08-11 Guggenhime Andrew (COO and CFO) Option Ex 10,000 5.51 55,100
2016-08-01 Ringo William R Sale 500 33.65 16,825
2016-08-01 Ringo William R Option Ex 500 16.00 8,000
2016-08-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 33.18 82,950
2016-08-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 32.91 362,065
2016-07-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Sale 1,303 30.02 39,116
2016-07-15 Griffith Christopher M. (VP Corp. Dev. & Strategy) Option Ex 1,303 1.48 1,927
2016-07-11 Guggenhime Andrew (COO and CFO) Sale 10,000 30.04 300,400
2016-07-11 Guggenhime Andrew (COO and CFO) Option Ex 10,000 5.51 55,100
2016-07-05 Wiggans Thomas G (CEO & Chairman of the Board) Sale 2,000 30.18 60,360
2016-07-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 29.48 73,700
2016-07-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 9,000 29.49 265,410
2016-06-23 Pena Luis C. (Chief Development Officer) Sale 10,000 30.01 300,100
2016-06-23 Pena Luis C. (Chief Development Officer) Option Ex 10,000 1.74 17,400
2016-06-15 Pena Luis C. (Chief Development Officer) Sale 10,000 29.47 294,700
2016-06-15 Pena Luis C. (Chief Development Officer) Option Ex 10,000 .91 9,110
2016-06-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 31.65 79,125
2016-06-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 31.34 344,795
2016-05-02 Bauer Eugene A (Chief Medical Officer) Sale 2,500 25.09 62,725
2016-05-02 Wiggans Thomas G (CEO & Chairman of the Board) Sale 9,000 25.11 225,990
2016-04-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 20.84 52,100
2016-04-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 7,000 20.69 144,830
2016-02-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 27.57 68,937
2016-02-01 Wiggans Thomas G (CEO & Chairman of the Board) Sale 9,000 27.56 248,040
2016-01-04 Bauer Eugene A (Chief Medical Officer) Sale 2,500 33.49 83,725
2016-01-04 Wiggans Thomas G (CEO & Chairman of the Board) Sale 11,000 33.54 368,940
2015-12-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 30.02 75,050
2015-11-02 Bauer Eugene A (Chief Medical Officer) Sale 2,500 27.75 69,375
2015-10-01 Bauer Eugene A (Chief Medical Officer) Sale 2,500 23.18 57,962
2015-09-14 Bauer Eugene A (Chief Medical Officer) Sale 22,500 28.26 635,850
2015-06-29 Fust Matthew K Option Ex 9,051 5.51 49,871
2014-11-25 Fust Matthew K Buy 6,000 16.77 100,602
2014-10-08 Canaan Partners Viii Llc Buy 49,276 16.00 788,416
2014-10-08 Viswanathan Ravi (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Nea Partners 13, Limited Partnership (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Bay City Capital Fund V Co-investment Fund, L.p. Buy 69,112 16.00 1,105,792
2014-10-08 Weller Harry R (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Hutton Wende S Buy 49,276 16.00 788,416
2014-10-08 Drant Ryan D (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Baskett Forest (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Kolluri Krishna Kittu (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Sandell Scott D (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Kerins Patrick J (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Mott David M (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Barrett M James (10% Owner) Buy 69,112 16.00 1,105,792
2014-10-08 Craves Fred B Buy 69,112 16.00 1,105,792
2014-10-08 Barris Peter J (10% Owner) Buy 69,112 16.00 1,105,792

Insider trading activities including stock purchases, stock sales, and option exercises of DERM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dermira, Inc. (symbol DERM, CIK number 1557883) see the Securities and Exchange Commission (SEC) website.